title: [Perioperative management of thyroid surgery in patients treated with drug-eluting stents].
abstract: The use of drug-eluting stents (DES) has been spreading worldwide to treat coronary heart disease. Patients treated with DES need long-term dual antiplatelet therapy with aspirin and thienopyridine to prevent stent thrombosis. Perioperative management is important to prevent postoperative complications in thyroid surgery if thyroid surgery is considered in patients who have been treated with DES. However, no evidence exists regarding the safety of perioperative management in patients treated with DES. We reviewed two cases of patients undergoing thyroid surgery after DES implantation. In the two cases, our protocol was adopted for perioperative management, and postoperative complications were assessed. Our thyroid surgeries were performed safely and free from serious complications such as stent thrombosis and postoperative bleeding. Under our protocol, patients after DES implantation were safely treated without severe complications. We believe that our protocol for perioperative management is useful for thyroid surgery.
authors.forename: Tsunehisa
authors.initials: T
authors.lastname: Ohno
authors.forename: Akifumi
authors.initials: A
authors.lastname: Mizukoshi
authors.forename: Toshiya
authors.initials: T
authors.lastname: Kimura
authors.forename: Hisanobu
authors.initials: H
authors.lastname: Tamaki
mesh_terms: D000368:Aged; D054855:Drug-Eluting Stents; D006801:Humans; D008297:Male; D019990:Perioperative Care; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D013964:Thyroid Neoplasms / Q000601:surgery*
chemical_list: D010975:Platelet Aggregation Inhibitors